Anteris Technologies Enters into Agreement with Switchback Medical for Development, Manufacturing Services
MT Newswires Live
Jul 30, 2025
Anteris Technologies (ASX:AVR) said on Monday it entered into an amended and restated master services agreement with Switchback Medical, under which Switchback will provide development and manufacturing services, including engineering and testing services, according to a Wednesday Australian bourse filing.
The agreement expires on March 31, 2028, and will automatically renew for successive one-year terms unless terminated by one of the firms.
Anteris granted Switchback a limited, exclusive, revocable, non-sublicensable, fully paid-up, royalty-free license to certain of its intellectual property to be used only for manufacturing during the term of the agreement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.